Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Sarinc Ulasli, B. Akinci Ozyurek, E. Bozkurt Yilmaz, G. Ulubay (Ankara, Turkey). Can mean platelet volume be an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease?. Eur Respir J 2009; 34: Suppl. 53, 3148

Member's Comments

No comment yet.

Related content which might interest you: Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Platelets activation during chronic obstructive pulmonary disease (COPD) exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 89s Year: 2002 Evaluation of mean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD exacerbation Year: 2012 The role of neutrophil/lymphocyte ratio in acute exacerbations of chronic obstructive pulmonary disease COPD Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 Role of endothelial dysfunction, disturbance of haemostatic reactions in pathogenesis of acute exacerbation of chronic obstructive pulmonary disease (AE COPD) Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Inflammatory changes, recovery and recurrence at COPD exacerbation Source: Eur Respir J 2007; 29: 527-534 Year: 2007 Systemic inflammation in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 5S-13S Year: 2003 Platelet characteristics of patients with chronic obstructive pulmonary disease (COPD) accompanied with lung hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 226s Year: 2007 High interleukin-33 is associated with acute exacerbation in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Is increased gastro-intestinal permeability related to exacerbation in patients with chronic obstructive pulmonary disease? Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Systemic effects of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 347-360 Year: 2003 Pulmonary rehabilitation of patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation Year: 2010 Eosinopenia as a prognostic factor in patients with acute exacerbation of chronic obstructive pulmonary disease. Source: International Congress 2017 – COPD and weaning Year: 2017 Acute coronary events during acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007 The rate of pulmonary thromboembolism in acute exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 297s Year: 2005 Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 325-331 Year: 2002 Platelets count in chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD comorbidities I Year: 2012 Clinical value of C-reactive protein in severe acute exacerbations of COPD Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005 Systemic inflammation and increased arterial stiffness in patients with chronic obstructive pulmonary disease Source: Annual Congress 2006 - COPD and inflammation Year: 2006